https://vst-bio.com/article-title6/2026-01-24T01:36:55+00:00https://vst-bio.com/anti-syndecan-2-human-monoclonal-antibody-for-treatment-of-stroke-associated-edema/2026-02-04T23:32:33+00:00https://vst-bio.com/anti-syndecan-2-human-monoclonal-antibody-for-treatment-of-stroke-associated-edema-2/2026-02-04T23:32:03+00:00https://vst-bio.com/vst-bio-corporation-announces-series-a-financing-to-advance-vb-001-and-adds-william-sessa-to-board-of-directors/2026-03-17T17:37:56+00:00